Ignite Creation Date:
2025-12-24 @ 5:01 PM
Ignite Modification Date:
2025-12-28 @ 9:13 AM
Study NCT ID:
NCT01351350
Status:
COMPLETED
Last Update Posted:
2019-08-08
First Post:
2011-02-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Dose Escalation Study of MLN0128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid Malignancies
Sponsor:
Millennium Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-02-28
Start Date Type:
ACTUAL
Primary Completion Date:
2017-09-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-09-15
Completion Date Type:
ACTUAL
First Submit Date:
2011-02-21
First Submit QC Date:
None
Study First Post Date:
2011-05-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-02-13
Results First Submit QC Date:
None
Results First Post Date:
2019-08-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-06-28
Last Update Post Date:
2019-08-08
Last Update Post Date Type:
ACTUAL